Healthscope gets revised takeover offer from Brookfield

Company News

by Anna Napoli

Healthscope (ASX:HSO) has received a revised takeover offer from Brookfield Capital Partners.

The proposal is for acquisition of all shares in Healthscope by way of and off-market takeover offer of $2.42 cash per share and a simultaneous scheme of arrangement of $2.55 per share.

Healthscope has knocked back rival bidder BGH Capital's request for due diligence on the basis that the proposal is significantly less attractive than the Brookfield proposal.

Brookfield on the other hand has been granted exclusive due diligence to facilitate a binding offer for Healthscope.

Last month BGH Capital and its partners put forward a $4.1 billion bid for the private healthcare provider.

Shares in Healthscope (ASX:HSO) are trading 10.82 per cent higher to $2.31.

 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.